Cargando…
Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for management
Immune checkpoint inhibitors are a new class of oncologic drugs that act via the inhibition of checkpoints, thereby unlocking the immune system to attack cancer cells. Their emergence has radically changed the concept of therapy in oncologic patients. However, despite their overall favorable profile...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721136/ https://www.ncbi.nlm.nih.gov/pubmed/35005180 http://dx.doi.org/10.1016/j.ijwd.2021.10.005 |